A systems approach to cancer therapy
- 1 June 1996
- journal article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 15 (2) , 247-272
- https://doi.org/10.1007/bf00437479
Abstract
No abstract availableKeywords
This publication has 215 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Suppression of Cyclin D1 mRNA Expression by the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1994
- Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance geneBiochemical and Biophysical Research Communications, 1991
- Treatment of childhood angiomatous diseases with recombinant interferon alfa-2aThe Journal of Pediatrics, 1991
- Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoidesJournal of the American Academy of Dermatology, 1989
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular responseBiochemical and Biophysical Research Communications, 1987
- Fibronectin-degrading proteases from the membranes of transformed cellsCell, 1987
- Partial purification of a 5.7K glycoprotein from bovine vitreous which inhibits both angiogenesis and collagenase activityBiochemical and Biophysical Research Communications, 1985
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889